Larvol Delta - Case-Report-Anifrolumab-for-Refractory-Cutaneous-Lupus-Erythematosus-Relapse-After-Treatment-Interruption-and-Response-to-Rechallenge

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42735674

Farina Tariq; Muhammad Zaheer; Seth Stidham; Yuanzun Peng

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next